The platform will undergo maintenance on Sep 14 at about 7:45 AM EST and will be unavailable for approximately 2 hours.
2023
DOI: 10.1136/bmjopen-2023-072557
|View full text |Cite
|
Sign up to set email alerts
|

Randomised double-blind controlled trial of non-invasive preimplantation genetic testing for aneuploidy in in vitro fertilisation: a protocol paper

Abstract: IntroductionThe success rate of in vitro fertilisation (IVF) treatment for couples with infertility remains low due to lack of a reliable tool in selecting euploid embryos for transfer. This study aims to compare the efficacy in embryo selection based on morphology alone compared with non-invasive preimplantation genetic testing for aneuploidy (niPGT-A) and morphology in infertile women undergoing IVF.Methods and analysisThis is a randomised double-blind controlled trial conducted in two tertiary assisted repr… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(3 citation statements)
references
References 26 publications
0
3
0
Order By: Relevance
“…One pivotal advancement lies in developing non-invasive approaches that scrutinize cell-free DNA (cfDNA) extracted from the blastocoel or embryo culture media, thus preventing the need for invasive embryo biopsies. This innovative method facilitates the evaluation of genetic status without directly impacting the embryo, mitigating the risk of damage and enhancing the overall viability of embryos [ 58 , 59 ]. Moreover, integrating sophisticated technologies such as NGS and SNP arrays into non-invasive PGT techniques has facilitated the simultaneous assessment of monogenic and chromosomal abnormalities at heightened resolution.…”
Section: Reviewmentioning
confidence: 99%
“…One pivotal advancement lies in developing non-invasive approaches that scrutinize cell-free DNA (cfDNA) extracted from the blastocoel or embryo culture media, thus preventing the need for invasive embryo biopsies. This innovative method facilitates the evaluation of genetic status without directly impacting the embryo, mitigating the risk of damage and enhancing the overall viability of embryos [ 58 , 59 ]. Moreover, integrating sophisticated technologies such as NGS and SNP arrays into non-invasive PGT techniques has facilitated the simultaneous assessment of monogenic and chromosomal abnormalities at heightened resolution.…”
Section: Reviewmentioning
confidence: 99%
“…Assisted reproduction techniques have significantly contributed to enabling conception for many infertile couples. However, despite advancements in ovarian stimulation, culture mediums, and laboratory conditions, the success rates for pregnancy and live births per transfer stand at approximately 35%-45% and 25%-36%, respectively [6,7].…”
Section: Introductionmentioning
confidence: 99%
“…Recurrent implantation failure (RIF) poses a profound challenge for both couples and medical professionals, signifying the absence of pregnancy despite the use of high-quality embryos and without discernible causes. Chromosomal aberrations constitute a leading cause of pregnancy failure, miscarriage, and congenital anomalies in both natural conception and pregnancies resulting from in vitro fertilization (IVF) [6].…”
Section: Introductionmentioning
confidence: 99%